`To:
`Cc:
`
`Subject:
`Date:
`Attachments:
`
`Brausa, Adam R.
`Trials; Matthew Traupman
`Durie, Daralyn J.; Davis, Kira A; Weires, Rebecca; Regeneron-MoFo-IPR; Ray Nimrod; Laura Fairneny; Zach
`Summers; Elliot Choi; Landon Smith; QE - Samsung Bioepis; MYL_REG_IPR@rmmslegal.com;
`lgreen@geminilaw.com; fchu@geminilaw.com; Robert Cerwinski; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com
`IPR2023-00884: Notice of disclaimer/request to terminate proceedings
`Wednesday, July 10, 2024 10:53:27 PM
`image001.png
`Disclaimer 7-10-24 US 11,253,572.pdf
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Dear Honorable Board,
`
`Counsel for Patent Owner writes to notify the Board that Patent Owner has filed a Disclaimer under
`37 CFR 1.321(a), disclaiming claims 1-30 in U.S. Patent No. 11,253,572 that are the subject of
`IPR2023-00884. The Disclaimer was filed via Patent Center with the U.S. Patent and Trademark
`Office today and is attached. As a result of the disclaimer, no challenged claims remain and Patent
`Owner therefore requests termination of the proceedings. Please advise whether any additional
`filings should to be made or any further steps taken to request termination of the present
`proceeding.
`
`Regards,
`Adam R. Brausa (Reg No. 60,287)
`Lead Counsel For Patent Owner
`
`
`Adam Brausa
`abrausa@mofo.com
`T: +1 (415) 268-6053
`M: +1 (773) 426-9492
`
`Morrison Foerster
`425 Market St.
`San Francisco, CA 94105
`
`
`
`mofo.com | LinkedIn | Twitter
`
`
`===================================================================
`=========
`
`This message may be confidential and privileged. Use or disclosure by anyone other than an intended
`
`
`
`addressee is prohibited. If you received this message in error, please delete it and advise the sender by
`reply email. Learn about Morrison & Foerster LLP's Privacy Policy.
`.
`
`